What amount sold does PREDIMYA Inc. report in Form D filings?

The latest linked filings report $25M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was PREDIMYA Inc.'s most recent SEC filing?

PREDIMYA Inc.'s most recent Form D filing was on 2025-01-06.

How many investors does PREDIMYA Inc. have?

The most recent Form D filing lists 6 investor(s).

What type of securities does PREDIMYA Inc. offer?

PREDIMYA Inc.'s SEC Form D filings indicate equity offerings.

PREDIMYA Inc.

CIK: 0002022164·Other·NEW YORK, NY·Corporation·Founded 2024

Reported Sold

$25,001,955

Total Filings

Identified Offerings

Last Filed

Jan 6, 2025

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Jan 6, 2025Form D — New notice

Reported sold: $9,999,999 · Target: $9,999,999

Rule 506(b)·6 investors

Jun 11, 2024Form D — New notice

Reported sold: $15,001,956 · Target: $15,001,956

Rule 506(b)·6 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 2 identified offerings

$25,001,955

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Sebastian Cesario

Related Person

Appears on 2 filings

Luigi Lenguito

Related Person

Appears on 2 filings

Luciano Allegro

Related Person

Appears on 2 filings

Jay Leek

Related Person

Appears on 2 filings

Kristjan LAANEMAA

Related Person

Appears on 2 filings

Stu Solomon

Related Person

Appears on 1 filing

Jarrod Scuglik

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 6, 2025	New	$9,999,999	$9,999,999	6
Jun 11, 2024	New	$15,001,956	$15,001,956	6

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Altrartis Therapeutics Inc.

Other

Offering target: $10,999,977

Filed Oct 22, 2026